Branded - Levagen


Levagen® contains palmitoylethanolamide (PEA) and has been clinically studied for its ability to manage discomfort and support joint function. PEA has also been said to contribute to relaxation and restfulness leading to a better quality of sleep.

In addition to this, we also have Levagen® with LipiSperse® technology which has been developed by award-winning Pharmako Biotechnologies, to increase functionality and bioavailability of PEA for food and beverage applications.

The Levagen® range includes:

  • P11786 - Levagen®
  • P12173 - Levagen® with LipiSperse® technology 
  • P12454 - Levagen® capsule
  • P12175 - Levagen® effervescent tablet

Click here to request a FREE sample of Levagen®

Subscribe to receive a copy of the CCL email newsletter